Stephanie Vanterpool, MD
Pain Medicine · Knoxville, TNNPI 1659595270
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 41 manufacturers reported payments, led by Nevro Corp. at 37.6% of the total. Reporting peaked in 2019 at $39,300 and has fallen 96.0% since, to $1,559 in 2025. Among pain medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 423 payments — averaging $162.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$26K
- Boston Scientific$22K
- Pfizer$7K
- Saluda Medical Americas, Inc.$3K
- Medtronic$2K
- Abbott$2K
- plus $7K from 35 others
Across 2 payments — averaging $1552.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nevro Corp.$3K
- Saluda Medical Americas, Inc.$105
What the payments were for
- Consulting fees$14,25021%
- Speaking & faculty fees$27,06339%
- Travel & lodging$14,18721%
- Food & beverage$13,21819%
- Entertainment$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza Spinal Cord Stimulation System$22,161
- SPECTRA WAVEWRITER$13,815
- Evoke$3,007
- GENERAL - THERAPIES$2,997
- Omnia$2,478
- Superion ISS$1,606
- Prospera$1,523
- GENERAL PAIN MANAGEMENT$1,417
- INTELLIS$1,292
- Neuromodulation Dspsbls and Accs$506
- ReActiv8$493
- ETERNA$446
- Evoke SCS$271
- Infinion 16$167
- mild Device Kit$130
- WaveWriter Alpha Prime 16$124
- SPRINT PNS System$123
- StimQ Receiver Stimulator Kit Channel A US w Receiver$117
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$117
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$117
How this compares
$68,752 in reported general payments places this provider in the 95th percentile of 112 pain medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Potassium | 21 | $63,386 |
| Fentanyl | 34 | $4,123 |
| Clobetasol Propionate | 14 | $1,777 |
| Morphine Sulfate ErMorphine Sulfate | 34 | $1,153 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 39 | $825 |
| Morphine Sulfate | 12 | $532 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $416 |
| Pregabalin | 11 | $324 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Knoxville
- Joseph DichiaraKnoxville$102K
- Kyle SnyderKnoxville$8K
- James ChooKnoxville$5K
- George MearsKnoxville$4K
- Matthew VanceKnoxville$3K
- Shravani DurbhakulaNashville$353K
- Herbert MeltzerNashville$43K
- Marc HuntoonNashville$37K
- Gregory BallChattanooga$35K
- Phillip GreenMemphis$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.